FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine, namely to ophthalmology, and concerns prevention of proliferative vitrioretinopathy, which develops as a result of proliferation of retinal glial cells and leads to formation of a choreoretinal scar. Method consists in fact that 0.02 ml of 0.5 % aqueous solution of D-asparagine is introduced intravitreally once into animal on 1st–6th day of the onset of the disease.
EFFECT: invention allows to considerably reduce the risk of developing proliferative vitrioretinopathy and improve retinal integrity.
1 cl, 4 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HYDROGEL FOR CORRECTING THE POST-TREPANATION DEFECT OF THE SKULL | 2017 |
|
RU2666595C1 |
| AGENT FOR PREVENTING PATHOLOGICAL SKIN SCARS FORMATION | 2018 |
|
RU2691647C1 |
| METHOD FOR CORRECTION OF HYPOGONADISM IN ANIMALS DURING SIMULATION OF ACUTE INJURY OF SPINAL CORD | 2017 |
|
RU2689114C2 |
| COMPOSITION FOR PREVENTING AND TREATING INFLAMMATORY DISEASES OF ORAL CAVITY | 2019 |
|
RU2716501C1 |
| PREPARATION FOR GLIAL SCARS PREVENTION | 2017 |
|
RU2651756C1 |
| HYDROGEL FOR REGENERATION OF TOOTH PULP AND PERIODONTIUM | 2019 |
|
RU2700933C1 |
| HYDROGEL TO SUBSTITUTE DEFECTS OF BIOLOGICAL TISSUE | 2017 |
|
RU2643922C1 |
| METHOD FOR SIMULATING PROLIFERATIVE VITREORETINOPATHY | 2014 |
|
RU2568368C1 |
| METHOD FOR SIMULATING PROLIFERATIVE VITREORETINOPATHY IN RATS | 2014 |
|
RU2563368C1 |
| SAMPLE FIXATOR FOR CYTOLOGICAL EXAMINATION | 2016 |
|
RU2630983C1 |
